Brief: Nutra Pharma Responds To FDA Warning Letter

Nutra Pharma

10/04/2019 13:37

April 10 (Reuters) - Nutra Pharma Corp  NPHC.PK :
    * NUTRA PHARMA RESPONDS TO FDA WARNING LETTER
    * NUTRA PHARMA CORP - WILL MAKE CHANGES NECESSARY TO
PROPERLY AND
LEGALLY CONTINUE TO MARKET AND DISTRIBUTE ITS PRODUCTS
    * NUTRA PHARMA CORP - RESPONDED TO FDA WARNING LETTER
REGARDING
WEBSITE & SOCIAL MEDIA SITES FOR SALES AND MARKETING OF THEIR
NYLOXIN® PRODUCTS
    * NUTRA PHARMA CORP - "BELIEVE THAT FORMULAE CONTAINED IN
NYLOXIN
PRODUCTS MEETS STANDARDS SET FORTH IN HPUS MONOGRAPH"
    * NUTRA PHARMA CORP - FDA HAS CONCERNS WITH LABELING,
BRANDING AND
CLAIMS ASSERTED IN CONNECTION WITH NYLOXIN PRODUCTS

Source text for Eikon:  ID:nGNX4tc7c 
Further company coverage:  NPHC.PK 

 ((Reuters.Briefs@thomsonreuters.com;))